Follow
CHAGRAOUI abdeslam
CHAGRAOUI abdeslam
French Institute of Health and Medical Research Paris, France, Université de Rouen, Normandy
Verified email at univ-rouen.fr - Homepage
Title
Cited by
Cited by
Year
Long-Term Heart Rate Reduction Induced by the Selective If Current Inhibitor Ivabradine Improves Left Ventricular Function and Intrinsic Myocardial Structure in …
P Mulder, S Barbier, A Chagraoui, V Richard, JP Henry, F Lallemand, ...
Circulation 109 (13), 1674-1679, 2004
4372004
Tissue Doppler imaging differentiates physiological from pathological pressure-overload left ventricular hypertrophy in rats
G Derumeaux, P Mulder, V Richard, A Chagraoui, C Nafeh, F Bauer, ...
Circulation 105 (13), 1602-1608, 2002
2182002
High-affinity [3H] GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system
JJ Bonnet, P Protais, A Chagraoui, J Costentin
European journal of pharmacology 126 (3), 211-222, 1986
1231986
Selenoprotein T exerts an essential oxidoreductase activity that protects dopaminergic neurons in mouse models of Parkinson's disease
L Boukhzar, A Hamieh, D Cartier, Y Tanguy, I Alsharif, M Castex, A Arabo, ...
Antioxidants & Redox Signaling 24 (11), 557-574, 2016
1182016
5-HT2C receptors in psychiatric disorders: a review
A Chagraoui, F Thibaut, M Skiba, C Thuillez, M Bourin
Progress in Neuro-Psychopharmacology and Biological Psychiatry 66, 120-135, 2016
1142016
L-DOPA in parkinson’s disease: Looking at the “false” neurotransmitters and their meaning
A Chagraoui, M Boulain, L Juvin, Y Anouar, G Barrière, ...
International journal of molecular sciences 21 (1), 294, 2019
732019
The PACAP-regulated gene selenoprotein T is highly induced in nervous, endocrine, and metabolic tissues during ontogenetic and regenerative processes
Y Tanguy, A Falluel-Morel, S Arthaud, L Boukhzar, DL Manecka, ...
Endocrinology 152 (11), 4322-4335, 2011
712011
Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats
A Chagraoui, P Protais, T Filloux, E Mocaër
Psychopharmacology 170, 17-22, 2003
622003
Enantioselective Syntheses of Dopaminergic (R)- and (S)-Benzyltetrahydroisoquinolines
N Cabedo, I Andreu, MC Ramirez de Arellano, A Chagraoui, A Serrano, ...
Journal of medicinal chemistry 44 (11), 1794-1801, 2001
572001
Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors
M Vasse, A Chagraoui, P Protais
European journal of pharmacology 148 (2), 221-229, 1988
551988
Constitutive activity of 5-HT receptors: Factual analysis
P De Deurwaerdère, R Bharatiya, A Chagraoui, G Di Giovanni
Neuropharmacology 168, 107967, 2020
532020
Structure–affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors: halogenation and D1 receptor selectivity
M Asencio, C Hurtado-Guzmán, JJ López, BK Cassels, P Protais, ...
Bioorganic & medicinal chemistry 13 (11), 3699-3704, 2005
462005
In vivo binding of [3H] GBR 12783, a selective dopamine uptake inhibitor, in mouse striatum
A Chagraoui, JJ Bonnet, P Protais, J Costentin
Neuroscience letters 78 (2), 175-179, 1987
351987
WFSBP and IAWMH Guidelines for the treatment of alcohol use disorders in pregnant women
F Thibaut, A Chagraoui, L Buckley, F Gressier, J Labad, S Lamy, ...
The World Journal of Biological Psychiatry 20 (1), 17-50, 2019
332019
Effects of some antioxidative aporphine derivatives on striatal dopaminergic transmission and on MPTP-induced striatal dopamine depletion in B6CBA mice
F Loghin, A Chagraoui, M Asencio, E Comoy, H Speisky, BK Cassels, ...
European journal of pharmaceutical sciences 18 (2), 133-140, 2003
332003
Interactions of amineptine with the neuronal dopamine uptake system: Neurochemicalin vitro andin vivo studies
JJ Bonnet, A Chagraoui, P Protais, J Costentin
Journal of neural transmission 69, 211-220, 1987
321987
Lorcaserin bidirectionally regulates dopaminergic function site-dependently and disrupts dopamine brain area correlations in rats
P De Deurwaerdère, M Ramos, R Bharatiya, E Puginier, A Chagraoui, ...
Neuropharmacology 166, 107915, 2020
292020
Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson's disease animal models
I Alsharif, L Boukhzar, B Lefranc, D Godefroy, J Aury-Landas, JL Do Rego, ...
Redox biology 40, 101839, 2021
262021
Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents
P Protais, A Chagraoui, J Arbaoui, E Mocaër
European journal of pharmacology 271 (1), 167-177, 1994
261994
Neurochemical impact of the 5-HT2C receptor agonist WAY-163909 on monoamine tissue content in the rat brain
A Chagraoui, S Whitestone, L Baassiri, J Manem, G Di Giovanni, ...
Neurochemistry International 124, 245-255, 2019
242019
The system can't perform the operation now. Try again later.
Articles 1–20